Cross Country Healthcare (NASDAQ: CCRN) announced today it has
completed the previously announced sale of its clinical trial services
business to ICON plc (NASDAQ: ICLR) for $52 million, plus an earn-out of
up to $3.75 million...
plc, (NASDAQ: ICLR) today announced that it has agreed,
subject to certain closing conditions, to acquire the Clinical Trial
Services Division of Cross
Country Healthcare, Inc. (NASDAQ: CCRN), for a cash...
Bon-Ton Stores (Nasdaq: BONT) 21.2% HIGHER; KeyBanc upgraded Bon-Ton Stores from Hold to Buy with a price target of $15. Click here for more color.
AuRico Gold (NYSE: AUQ) 19.5% LOWER; provided by the miner for its Ocampo Mine site in Mexico. ...
Analysts at Piper Jaffray upgraded Codexis (NASDAQ: CDXS) from “underweight” to “neutral.” Codexis' shares closed at $2.20 yesterday. Codexis' trailing-twelve-month revenue is $120.82 million.
Deutsche Bank upgraded Williams-Sonoma...
Citigroup raised its rating on Cross Country Healthcare (NASDAQ: CCRN) from Neutral to Buy and established a price target of $7 a share.
Citigroup commented, "We are upgrading shares of CCRN from Neutral to Buy and establishing a 12month price...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Cross Country Healthcare (CCRN):